In this review, we describe the various characteristics of the multiple levels of heterogeneity of TP53 variants in CLL through the analysis of TP53 mutation databases and the utility of their diagnosis in the clinic. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.